Showing results (3301-3310 of 6,794) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|August 15, 2025
Real-World Utilization Patterns of Immune Checkpoint Inhibitors Based on the National Health Insurance Service Data in KoreaEunji Kim, Yu-Seon Jung, Jongmin Lee, et al.Clinical Therapeutics|August 6, 2025
The Impact of Azithromycin on Lung Function in Children And Adolescents with Cystic Fibrosis: A Systematic Review And Meta-AnalysisKangping Wu, Suling Wu, Lina WangClinical Therapeutics|August 1, 2025
Tranexamic Acid for Preventing Secondary Post-Tonsillectomy Bleeding: Insights From A Retrospective Cohort StudySomaya Koraysh, Lina Naseralallah, Zahra Noureddine, et al.Clinical Therapeutics|November 12, 2025
Statin Treatment Is Associated With a Higher Risk of Carpal Tunnel Syndrome, But not of Ulnar Nerve Entrapment, in Type 2 Diabetes-A Nationwide Register StudyMalin Zimmerman, Raquel Perez, Juan Merlo, et al.Clinical Therapeutics|October 29, 2025
Multicenter, Randomized, Double-Blind, Parallel, Phase 2 Clinical Trial to Compare and Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential HypertensionJinho Shin, SeongHwan Kim, KiHoon Han, et al.Clinical Therapeutics|July 22, 2025
Cost-Effectiveness of Antiarrhythmic Drugs for Treating Paroxysmal or Persistent Atrial Fibrillation in China: An Economic EvaluationFuming Li, Dunming Xiao, Yu Xia, et al.Clinical Therapeutics|July 10, 2025
Pharmacokinetic Drug Interactions of TPN171 When Coadministration With Rifampicin or ItraconazoleLiyu Liang, Haiping Qin, Gangyi Liu, et al.Clinical Therapeutics|June 27, 2025
Comparison of Effects of Dipeptidyl Peptidase-4 Inhibitors and Sulfonylureas in Combination with Metformin: A Hospital-Based Cohort Study of Patients With Type 2 DiabetesJui Wang, Kuo-Liong Chien, Hon-Yen WuClinical Therapeutics|June 26, 2025
Candesartan for Treatment of Migraine Headache: A Scoping ReviewEna Elizabeth L Naoe, Mykha Marie B Tabuzo, Roland Dominic G JamoraClinical Therapeutics|September 19, 2025
Biomarkers as Surrogate Endpoints in Drug Development: Finding Their Right PlaceKatarina IlicPageof 680